Health Condition 1: K80- Cholelithiasis Health Condition 2: C50- Malignant neoplasm of breast Health Condition 3: 8- Other Procedures
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Patients for elective surgery planned under general anaesthesia of American Society of Anaesthesiologists (ASA) Physical Status I & II 2) Age group 20-60 years of either gender, giving valid informed and written consent
Exclusion criteria
Exclusion criteria: 1) Patient refusal 2) Anticipated difficult airway 3) Morbid obesity 4) ASA Physical Status III and IV 5) Known case of hypertension 6) Drug allergy to any anaesthetic medication/study drugs 7) Pregnant patients 8) Patients on sedatives, hypnotics or sympatholytics
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1) To evaluate the efficacy of oral Pregabalin 150mg for attenuation of haemodynamic response to laryngoscopy and tracheal intubation. 2) To evaluate the efficacy of oral Clonidine 200µg for attenuation of haemodynamic response to laryngoscopy and tracheal intubation. 3) To compare the efficacy of oral Pregabalin 150mg and oral Clonidine 200µg for attenuation of haemodynamic response to laryngoscopy and tracheal intubation. Timepoint: 1)Baseline(At time of premedication) (Tb) 2)30 minutes after premedication (T0.5) 3)60 minutes after premedication (T1) 4)90 minutes after premedication (Just before induction) (T1.5) 5)After induction (Just before intubation) (Ti) 6)Just after intubation (T0i) 7)1 minute after intubation (T1i) 8)2 minute after intubation (T2i) 9)3 minutes after intubation (T3i) 10)5 minutes after intubation (T5i) 11)8 minutes after intubation (T8i) 12)10 minutes after intubation (T10i) | — |
Secondary
| Measure | Time frame |
|---|---|
| To assess and compare preoperative sedation and anxiety with the use of oral Pregabalin 150mg and oral Clonidine 200µg.Timepoint: 1)Baseline 2)30 minutes 3)60 minutes 4)90 minutes | — |
Countries
India
Contacts
Baba Farid University of Health Sciences,Faridkot,Punjab